Neoplasms

3,817 trials 1,526 recruiting

Filter these 3,817 trials by phase, country and sponsor.

Open in Search →

A Phase 1 Study of BGB-B3227 Alone and in Combination With Tislelizumab in Patients With Advanced or Metastatic Solid Tumors Ended

2024-514216-27-00 Solid tumors 1 2025-01-17
PEMBROLIZUMAB IN MMR-PROFICIENT METASTATIC COLORECTAL CANCER PHARMACOLOGICALLY PRIMED TO TRIGGER DYNAMIC HYPERMUTATION STATUS - THE ARETHUSA… Ended

2024-518526-33-01 Metastatic colorectal cancer 4 2025-01-09
M9466 in Combination with Topoisomerase 1 Inhibitors-based Regimens in Advanced Solid Tumors and Colorectal Cancer (DDRiver 511) Ended

2024-514155-15-00 Advanced solid tumors and colorectal cancer 3 2025-01-08
With Ponatinib on the track for treatment-free-remission in chronic myeloid leukemia Ended

2024-518971-76-00 chronic myeloid leukemia in chronic phase 4 2024-12-21
A Window of Opportunity (WoO) study evaluating pembrolizumab with or without olaparib in Tertiary Lymphoid Structures (TLS)-positive selecte… Ended

2024-513469-38-00 Undifferentiated pleomorphic sarcoma and Dedifferentiat 4 2024-12-10
L19IL2/L19TNF in patients with non-melanoma skin cancer. Ended

2024-518530-92-00 Patients with high-risk, locally advanced (non-metastat 4 2024-12-09
A Phase I Open-Label, Dose-escalation Clinical Trial of Tumor Necrosis Factor Alpha and Interleukin-2 Coding Oncolytic Adenovirus TILT-123 i… Ended

2024-518088-37-01 Melanoma, SCCHN 3 2024-12-04
A phase I study of [177Lu]Lu-FF58 in patients with advanced solid tumors Ended

2022-502367-37-00 Recurrent glioblastoma multiforme (GBM) 7 2024-11-29
A Study to Learn About How Different Formulations of the Medicine Called Mevrometostat are Taken up Into the Blood in Healthy Adult Particip… Ended

2024-516907-18-00 Small cell lung cancer, Castration-resistant prostate c 3 2024-11-20
Adjuvant chemotherapy with gemcitabine and cisplatin compared to standard of care after curative intent resection of cholangiocarcinoma and … Ended

2024-517340-61-00 Patients after curative intent resection of cholangioca 5 2024-11-19
Evaluation of the safety and efficacy of Berubicin in the treatment of central nervous system lymphomas- BERUBICIN Ended

2024-516773-69-00 central nervous system (CNS) lymphomas 9 2024-11-18
SENtinel lymph node mapping with GAllium-68-tilmanocept PET/CT in high/high- intermediate risk endometrial cancer: a proof-of-concept study Ended

2024-516708-40-00 Endometrial cancer, uterine cancer 5 2024-11-15
A multicentre clinical trial to assess the safety and tolerability of the combination of low-dose cytarabine or azacitidine, plus Venetoclax… Ended

2024-519275-26-00 Newly diagnosed acute myeloid leukemia patients aged eq 9 2024-11-15
A Study to Learn About the Study Medicine Called PF-07220060 in Combination With Letrozole Compared to Letrozole Alone in Postmenopausal Wom… Ended

2024-512848-30-00 HORMONE RECEPTOR-POSITIVE, HER2-NEGATIVE BREAST CANCER 4 2024-11-12
Prospective and multicentre evaluation of 3 different doses of IV busulfan associated with fludarabine and thymoglobuline in the conditionin… Ended

2024-516435-27-00 High-risk myeloïd malignancies 4 2024-11-05
Impact of 18F-FES TEP on therapeutical management in patients with metastatic breast cancer, ER positive and HER2 negative, in relapse after… Ended

2024-517400-11-00 Patients with metastatic breast cancer initially presen 6 2024-10-24
A Phase I Study Using Hepatic Arterial Infusion of Autologous Tumor Infiltrating Lymphocytes in Patients with Melanoma and Liver Metastases Ended

2024-512877-28-00 Metastases to liver 3 2024-10-23
A clinical gene therapy study with hematopoietic stem cells for the treatment, with single dose of Temferon, of patients suffering from meta… Ended

2024-512898-27-00 Patients with locally advanced/metastatic renal cell ca 9 2024-10-22
A Study to Evaluate PK, Efficacy, and Safety of BAT3306 Plus Chemo and Compare With Keytruda®(EU/US) in Participants With IV nqNSCLC. Ended

2024-510640-32-00 Stage IV Non-squamous non-small cell lung cancer 5 2024-10-16
ImmunoTHerapy Adjacent to Cervical CAncer (ITHACA) study: safety, toxicity and immunological effects of peritumorally delivered immunotherap… Ended

2023-505968-11-00 Cervical Cancer 3 2024-10-15
Study of the benefit of lenvatinib treatment in waiting list of liver transplantation after TACE failure in patients with hepatocellular car… Ended

2024-516408-40-00 Non-resectable hepatocellular carcinoma (HCC) 9 2024-10-14
Safety of TEG001 in patients with r/r AML/high-risk MDS or r/r MM Ended

2024-517381-42-00 Acute Myeloid Leukemia (AML) 1 2024-10-14
A Study to Learn how Various Tablets of the Study Medicine Called Vepdegestrant are Taken up into the Blood in Healthy Adults Ended

2024-514169-21-00 ER+/HER2- Breast Cancer 3 2024-10-11
Phase Ib/II trial of the combination of atezolizumab with dendritic cell vaccination as maintenance treatment in patients with extensive sta… Ended

2024-518636-36-00 Lung Cancer 8 2024-10-10